Description
Difluoromethylenedioxyamphetamine, DiFMDA
Product information
IUPAC-name 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)propan-2-amine
Synonyms Difluoromethylenedioxyamphetamine, DiFMDA
Formal name 1-(2,2-Difluoro-1,3-benzodioxol-5-yl)propan-2-amine
Cas number 910393-51-0
Formula C10H11F2NO2
Molar Mass 215.200 g·mol−1
Purity 98.0 % min.
Formulation Powder, Solid, Crystals
Solubility
- DMF: 5 mg/ml
- DMSO: 10 mg/ml
- Ethanol: 0.3 mg/ml
- PBS (pH 7.2): 5 mg/ml
Difluoromethylenedioxyamphetamine, DiFMDA
A derivative of 3,4methylenedioxyamphetamine known as difluoromethylenedioxyamphetamine was developed and produced by Daniel Trachsel and his colleagues. It was designed to be a less harmful alternative to MDEA, MBDB, and MDMA. The goal of this project was to find a non-addictive drug that could be used as a replacement for MDMA. It was hoped that the drug would show better metabolic stability and lower toxicity.
Although the compounds have been studied in animal models to see if they show the same pharmacological properties as their non-fluorinated counterparts, they have not yet been tested in humans. In vitro binding studies also suggest that DFMDA has a SERT affinity similar to that of MDMA. However, there is a lack of bulk tolerance due to the reduced activity of the other idenidenedioxy analogues.
It has been widely accepted that the neurotoxic effects of MDMA are caused by various factors. It is not clear how much less harmful DFMDA and other similar compounds could be produced if they were to be used as a replacement for the illegal substance.
The toxicological and physiological properties of this compound has not been analyzed. Usage of this Chemical should be for research and forensic purposes only.
WARNING This product is not for human or veterinary use.
This product is only available to persons of 21 years old and above.
Hazard statement(s)
| H302 | Harmful if swallowed |
| H315 | Causes skin irritation |
| H319 | Causes serious eye irritation |
| H332 | Harmful if inhaled |
| H335 | cause respiratory irritation |
| H336 | cause drowsiness or dizziness |
| Precautionary statement(s) | |
| P264 | Wash hands thoroughly after handling |
| P280 | protective gloves/protective clothing/eye protection/face protection |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P337 + P313 | If eye irritation persists: Get medical advice/attention |
| P261 | Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray |
| P271 | Use only outdoors or in a well-ventilated area |
| P304 + P340 | IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed |
| P405 | Store locked up |
| P501 | Dispose of contents/container to a licensed disposal company |
Reviews
There are no reviews yet.